Germany’s Bayer has announced that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) to treat ...

South Korean biotech Illimis Therapeutics has raised 58 billion won ($42 million) in a series B round to advance its GAIA ...

Japan’s largest pharma company Taked today announced that all primary and secondary endpoints were met in two Phase III ...

The Flamma Group has celebrated the grand opening of its new cGMP plant in Dalian, China. A contract development and ...

The Amsterdam District Court has delivered a ruling in the lawsuit brought by Farma ter Verantwoording (FtV) — The ...

China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

China-based biotech CARsgen Therapeutics (HKEX: 2171) has strengthened its grip on intellectual property in the CAR-T space ...

UK pharma major AstraZeneca today announced positive high-level results from the baxdrostat BaxHTN Phase III trial in ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Lynkuet (elinzanetant) for the ...

Japanese drugmaker Eisai today revealed that it has launched its Urece (dotinurad) in China as a treatment for gout. Urece ...

German family-owned pharma major Boehringer Ingelheim and Denmark’s LEO Pharma today announced an exclusive global license ...

Even as the US Food and Drug Administration (FDA) has unveiled a strategic expansion of its oversight mechanisms for foreign ...